Spravato Nasal Spray for Depression | Wilshire Institute
Spravato (esketamine) is an innovative FDA-approved medication for depression, specifically designed to treat treatment-resistant #depression. It often provides relief when traditional medications have not been effective. #spravato, administered as a #nasalspray, targets the glutamate system and works differently from conventional therapies, offering rapid relief for many patients. If you or someone you care about is struggling with treatment-resistant depression or major depressive disorder, visit https://wilshireinstitute.com/spravato/ to learn how the Wilshire Institute for Interventional Psychiatry can help.